The Evidence Speaks (March 2022)
In recognition of Kidney Month, this edition features research on COVID vaccines and dialysis patients, self-management of glomerular disease, and sleep apnea's impact on CKD progression
Read MoreFebruary 4, 2022
In recognition of Kidney Month, this edition features research on COVID vaccines and dialysis patients, self-management of glomerular disease, and sleep apnea's impact on CKD progression
Read More
CHÉOS Scientists are leading nine of the projects funded in this round, plus a further seven projects are supported by CHÉOS Scientists as co-investigators
Read More
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read More
The 31st edition summarizes some of the latest research from CHÉOS Scientists, including epinephrine and out-of-hospital cardiac arrest, kidney disease treatment, and barriers to post-procedure cardiac care.
Read More
Drs. Sarah Munro, Joseph Puyat, and Wei Zhang received funding from the Michael Smith Foundation for Health Research this week
Read More
The 29th edition summarizes some of the latest research from CHÉOS Scientists, including patient preferences for rheumatoid arthritis prevention, a kidney disease risk-prediction tool, and sleep disturbance in adolescents.
Read More
Read about the Scientists and research that appeared in the media over the month.
Read More
Several CHÉOS Scientists will be front and centre at this year's BC Kidney Days event, taking place on November 1.
Read More
Drs. Anne Gadermann, Ehsan Karim, and Skye Barbic were recently announced as 2018 MSFHR Scholars
Read More
The twelfth installment in our series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read More